Q3 Earnings Estimate for McKesson Issued By Leerink Partnrs

McKesson Corporation (NYSE:MCK) – Equities researchers at Leerink Partnrs decreased their Q3 2026 EPS estimates for McKesson in a research report issued to clients and investors on Thursday, November 6th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $9.19 for the quarter, down from their prior estimate of $10.11. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share.

Other equities analysts have also recently issued reports about the company. UBS Group boosted their target price on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Wall Street Zen lowered McKesson from a “buy” rating to a “hold” rating in a report on Saturday. Wells Fargo & Company raised their target price on shares of McKesson from $816.00 to $914.00 and gave the company an “equal weight” rating in a research note on Monday. Cowen reiterated a “buy” rating on shares of McKesson in a research report on Wednesday, September 24th. Finally, Evercore ISI reissued an “outperform” rating and issued a $1,000.00 price target on shares of McKesson in a report on Thursday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $887.69.

McKesson Stock Performance

McKesson stock opened at $855.78 on Monday. McKesson has a fifty-two week low of $558.13 and a fifty-two week high of $867.63. The stock has a market cap of $106.44 billion, a P/E ratio of 34.12, a PEG ratio of 1.46 and a beta of 0.51. The firm’s fifty day moving average price is $764.28 and its 200-day moving average price is $726.81.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share for the quarter, topping analysts’ consensus estimates of $8.84 by $1.02. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business had revenue of $103.15 billion for the quarter, compared to analyst estimates of $103.80 billion. During the same quarter in the prior year, the firm posted $7.07 EPS. McKesson’s revenue was up 10.2% on a year-over-year basis.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 10.21%.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction on Friday, November 7th. The shares were sold at an average price of $861.63, for a total value of $283,476.27. Following the transaction, the chief accounting officer owned 328 shares in the company, valued at $282,614.64. This trade represents a 50.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Brian S. Tyler sold 11,930 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the sale, the chief executive officer owned 4,012 shares of the company’s stock, valued at approximately $2,830,987.56. The trade was a 74.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 24,189 shares of company stock valued at $16,787,319. Company insiders own 0.08% of the company’s stock.

Institutional Investors Weigh In On McKesson

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. GGM Financials LLC bought a new stake in McKesson in the third quarter valued at approximately $25,000. Solstein Capital LLC increased its stake in shares of McKesson by 171.4% in the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after buying an additional 24 shares during the period. Bank of Jackson Hole Trust boosted its position in McKesson by 64.3% during the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company’s stock valued at $29,000 after buying an additional 18 shares during the period. State of Wyoming purchased a new stake in McKesson during the 2nd quarter valued at $29,000. Finally, CBIZ Investment Advisory Services LLC grew its holdings in McKesson by 1,366.7% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company’s stock worth $30,000 after acquiring an additional 41 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.